SEC Form D filing

Jaguar Health, Inc., 2026-07-01

An SEC Form D private-offering notice from San Francisco, CA, a $40,800,000 filer-stated offering target in Biotech. Filed 2026-07-01. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Jaguar Health, Inc. Verified via SEC Form D

Commercial-stage pharmaceutical company developing plant-based, non-opioid prescription medicines for GI distress, including its FDA-approved drug Mytesi for HIV-related diarrhea.

Filed 2026-07-01Filed to raise $40,800,000First money in 2026-06-09Raised so far $40,800,000HQ (as filed) San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) Growth
Source linked the Form D on EDGAR↗Named in the filing 9 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • Jaguar Health, Inc., 2026-07-01, $40.8M EDGAR↗
  • Jaguar Health, Inc., 2026-07-01, $2M EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source